Daniel Guthy
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Acute Myeloid Leukemia Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Protein Degradation and Inhibitors 3
- Genomics and Chromatin Dynamics 3
- Epigenetics and DNA Methylation 2
- CRISPR and Genetic Engineering 2
- Biochemical and Molecular Research 2
- Oncology 6
- Cancer-related Molecular Pathways 2
- Co-authors
- Christine Fritsch (6 shared papers)Giorgio Caravatti (5 shared papers)Pilar Blancafort (2 shared papers)Marc Gerspacher (3 shared papers)Frédéric Stauffer (3 shared papers)Dirk Erdmann (2 shared papers)Kim S. Beyer (3 shared papers)Michael Kiffe (3 shared papers)
- Journals
- Cancer Research (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)ACS Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (1 paper)BMC Cancer (1 paper)
- Partner nations
- SwitzerlandUnited StatesChina
In The Last Decade
Daniel Guthy
14 papers receiving 241 citations
Peers
Comparison fields: 5 of 43
- Genetics 42
- Hematology 41
- Molecular Biology 192
- Pharmaceutical Science 15
- Organic Chemistry 40
Countries citing papers authored by Daniel Guthy
This map shows the geographic impact of Daniel Guthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Guthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Guthy more than expected).
Fields of papers citing papers by Daniel Guthy
This network shows the impact of papers produced by Daniel Guthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Guthy. The network helps show where Daniel Guthy may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Guthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 51 | |
| 2 | 2005 | 33 | |
| 3 | 2019 | 27 | |
| 4 | 2008 | 20 | |
| 5 | 2015 | 20 | |
| 6 | 2011 | 18 | |
| 7 | 2015 | 17 | |
| 8 | 2015 | 15 | |
| 9 | 2012 | 15 | |
| 10 | 2018 | 10 | |
| 11 | 2024 | 7 | |
| 12 | 2017 | 5 | |
| 13 | 2021 | 2 | |
| 14 | 2015 | 2 | |
| 15 | 2012 | 0 | |
| 16 | 2020 | 0 |
About Daniel Guthy
Daniel Guthy is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 16 papers that have together received 242 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Degradation and Inhibitors (3 papers), Genomics and Chromatin Dynamics (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Epigenetics and DNA Methylation (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer-related Molecular Pathways (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Genetics (42 citations), Hematology (41 citations), Molecular Biology (192 citations), Pharmaceutical Science (15 citations) and Organic Chemistry (40 citations). Daniel Guthy has collaborated with scholars based in Switzerland, United States and China. Frequent co-authors include Christine Fritsch, Giorgio Caravatti, Pilar Blancafort, Marc Gerspacher, Frédéric Stauffer, Dirk Erdmann, Kim S. Beyer, Michael Kiffe, Christoph Gaul and Robin A. Fairhurst. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Molecular Cancer Therapeutics and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.